Clinical and Economic Impact of Upfront Next-Generation Sequencing for Metastatic NSCLC in East Asia

por Loong, Herbert H., Wong, Carlos K.H., Chan, Catherine P.K., Chang, Andrea, Zhou, Zheng-Yi, Tang, Wenxi, Gibbs, Meaghan
Publicado 2022

Cost-effectiveness analysis of ceritinib vs. crizotinib in previously untreated anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) in Hong Kong

por Loong, Herbert H., Wong, Carlos K. H., Leung, Linda K. S., Chan, Catherine P. K., Chang, Andrea, Zhou, Zheng-Yi, Xie, Jipan, Gibbs, Meaghan
Publicado 2020